Viralytics Ltd Sp Ad Upgraded to “Hold” by Zacks (VRACY) June...

  1. 15,360 Posts.
    lightbulb Created with Sketch. 694
    Viralytics Ltd Sp Ad Upgraded to “Hold” by Zacks (VRACY)

    June 30th, 2015 - 0 comments - Filed Under - by Thomas Dobrow
    https://**promotion blocked**.com/assets/widget/stocktwits_share.png

    Zacks upgraded shares of Viralytics Ltd Sp Ad (NASDAQ:VRACY) from a sell rating to a hold rating in a research note issued to investors on Monday,Marketbeat.com reports.
    According to Zacks, “Viralytics Limited is a biotechnology company. The Company develops oncolytic virotherapy for the treatment of cancers. Oncolytic virotherapy makes use of the cancer destroying capabilities of a range of benign viruses. Viralytics Limited is headquartered in Sydney, Australia. “
    Zacks has also taken action a number of other stocks recently. The firm upgraded shares of Philippine Long Distance Telephone from a sell rating to a hold rating. Also, Zacks upgraded shares of Paragon Offshore PLC from a sell rating to a hold rating. Finally, Zacks upgraded shares of Grupo Aeroportuario del Pacifico from a hold rating to a buy rating. Zacks now has a $78.00 price target on that stock.
    Shares of Viralytics Ltd Sp Ad (NASDAQ:VRACY) remained flat at $1.52 during during mid-day trading trading on Monday. Viralytics Ltd Sp Ad has a 52-week low of $$0.01 and a 52-week high of $$2.25. The stock’s 50-day moving average is $0.95 and its 200-day moving average is $0.81. The company’s market cap is $93.20 million.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.